Extracorporeal Membrane Oxygen Machine Market Valued At $673 Million By 2026

ChicagoAnd November 26, 2021 /PRNewswire/ – According to a new market research report Extracorporeal membrane oxygenation machine market By product, ingredient, patient type (neonatal, pediatric, adult), condition outlook (venous venous, arteriovenous and arteriovenous), applications, and region – global outlook to 2026″, Published by MarketsandMarkets™, Global ECMO Machinery Market is expected to reach 673 million US dollars By 2026 estimates 531 million US dollars In 2021, at a compound annual growth rate of 4.9% from 2021 to 2026.

Markets and markets

Markets and markets

Browse in depth the table of contents Extracorporeal Membrane Oxygen Machine Market
171 – Tables
37 – Shapes
173 – Page

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654

Key factors driving the growth of this market include the increase in the number of elderly people and the growth in the incidence of diseases as well as favorable government regulations, investments and initiatives. The advantages of ECMO machines played a major role in its adoption; Their speed and accuracy, combined with fast processing times, allow for much higher patient examination volumes than before. This prompted companies to focus on product development and innovation.

The adult segment dominated the ECMO machine market in 2020

On the basis of patient type, the ECMO devices market is segmented into adult, neonatal, and neonatal. The adult segment captured the largest share of the global ECMO machine market in 2020. ECMO has been in use for over 40 years, and its benefits in neonates with respiratory distress are well recognized. The benefits of ECMO in adult patients with refractory heart failure or acute respiratory distress syndrome (ARDS) remain debated, as ECMO was initially associated with poor survival rates. However, recent technological advances in ECMO circuits have led to a lower rate of technical problems and complications.

ECMO mobile devices are expected to register the highest compound annual growth rate (CAGR) during the forecast period

On the basis of product type, the ECMO machines market is segmented into stationary ECMO machines and portable ECMO machines. The portable ECMO machine segment is expected to dominate the market during the forecast period. Portable ECMO machines can be moved to any desired location and are light in weight. These systems are particularly used in a variety of imaging groups, including intensive care units, cardiac care units, neonatal intensive care units, operating rooms and emergency rooms, and on the patient side for critically ill patients or patients with mobility difficulties.

Request form pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654

ECMO Machinery Segment Dominated ECMO Machine Market in 2020

The global ECMO machinery market is segmented into Pumps, Oxygen Concentrators, Controllers, Cannula and Accessories. The console segment is expected to dominate the market during the forecast period. The large share of this segment can be attributed to the increased adoption of the systems among the end users due to their lower cost compared to other systems.

Arterio-Venous Dominated ECMO Machine Market in 2020

Based on the method, the ECMO machine market is segmented into arteriovenous, venous, venous, and arteriovenous. The arteriovenous segment is expected to dominate the market during the forecast period. Arteriovenous ECMO facilitates gas exchange, particularly carbon dioxide removal, by using the patient’s arterial pressure to pump blood through the circuit. It is also referred to as the extracorporeal carbon dioxide removal (ECCO2 R) system, because it is more efficient at removing carbon dioxide. This is a major factor driving market growth.

The respiratory applications segment has dominated the ECMO machines market by applications in 2020

On the basis of applications, the ECMO devices market is segmented into respiratory, cardiac and ECPR applications. The general respiratory segment is expected to dominate this market during the forecast period. The growth in this market can be attributed to the increasing prevalence of target diseases, high demand for early diagnosis, and technological advancement in ECMO Machines market.

Talk to the analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=255167654

Asia Pacific The ECMO Machinery Market by Region is expected to witness the highest growth

The ECMO Machinery Market is segmented into five main regions – North America, EuropeAnd Asia PacificAnd Latin america, and the Middle east & Africa. North Amarica is the largest regional market for ECMO machines, while Asia Pacific The market is expected to grow at the highest compound annual growth rate (CAGR) during the forecast period.

Growth in ECMO Machinery Market in Asia Pacific Mainly driven by the increasing number of elderly people, especially in Japan; Increasing disposable income, which makes it possible to increase the affordability of advanced technologies; the increasing prevalence of target diseases; and favorable government initiatives. These factors help drive the market for digital imaging systems in this region and attract foreign investments and partnerships.

Getinge Group dominates (Sweden), Medtronic plc (US), Fresenius Medicalcare AG & Co. KGAA (Germany), microport (China), and Terumo Cardiovascular Systems Corporation (Japan). Other market leaders include Livanova plc (UK) and Nipro Corporation (Japan), Eurosets SRL (Italy), Origin Biomedical (US), Cytosorbents Corporation (Australia), and Abiomed (US).

Browse nearby markets: Medical Devices Market Research Reports and Consultations

Browse related reports:

respiratory care market By product (therapeutic (ventilator, mask, PAP device, inhaler, nebulizer), monitoring (pulse oximeter, Capnograph), diagnostics, consumables), end user (hospital, home care), impact of COVID-19 – forecast global up to 2026


heart pump market By product (ventricular assist devices (LVAD, RVAD, BiVAD, and pVAD), intra-aortic balloon pumps, TAH), type (extracorporeal and implantable pumps), treatment (bridge-to-implant, destination therapy) – global outlook to 2026


About MarketsandMarkets™

MarketsandMarkets™ provides quantitative business-to-business research on 30,000 high-growth niche opportunities/threats that will impact 70%-80% of corporate revenue worldwide. We currently serve 7,500 clients worldwide including 80% of global Fortune 1000 companies as clients. Nearly 75,000 senior officials in eight industries worldwide engage with MarketsandMarkets™ to learn their vulnerabilities around revenue decisions.

Our 850 full-time and SME analysts at MarketsandMarkets™ track global high-growth markets by following the Growth Engagement Model – GEM. GEM aims to proactively collaborate with customers to identify new opportunities, identify the most important customers, write “attack, avoid and defend” strategies, and identify incremental revenue sources for both the company and its competitors. MarketsandMarkets™ now delivers 1,500 MicroQuadrants (location of top players across leaders, startups, innovators and strategic players) annually in emerging high-growth sectors. MarketsandMarkets™ is determined to leverage over 10,000 companies this year to plan their revenue and help them take their early innovations/disruptions to market by providing them with advanced research.

Marketsand Markets’ platform for competitive information and leading market research, the “Knowledge Store” connects over 200,000 complete markets and value chains for a deeper understanding of unmet insights along with market size and niche market expectations.


the master. Mehra’s nest
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, Illinois 60062
United States of America: +1-888-600-6441
email: [email protected]
Research insight: https://www.marketsandmarkets.com/ResearchInsight/extracorporeal-membrane-oxygenation-systems-market.asp
Visit our website: https://www.marketsandmarkets.com
Content source: https://www.marketsandmarkets.com/PressReleases/extracorporeal-membrane-oxygenation-systems.asp



View original content:https://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-machine-market-worth-673-million-by-2026–exclusive-report-by-marketsandmarkets-301432318.html

SOURCE MarketsandMarkets

Write a Comment

Your email address will not be published. Required fields are marked *